Aptensio XR for Preschool Children With ADHD
About this title
Read the official source — NCT02683265Researchers compared Aptensio XR and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
Understand this study
What did researchers investigate?
Researchers compared Aptensio XR and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
Who was this study for?
Listed age limits: 4 years to 6 years.
- Listed locations
- Las Vegas and 1 more locationSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 158
- Sponsor
- Rhodes Pharmaceuticals, L.P.
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 4 Years to 6 Years
- Official registry ID
- NCT02683265
- Official title
Show the full official title
A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Aptensio XR® in Children Ages 4 to Under 6 Years Diagnosed With Attention Deficit-Hyperactivity Disorder (ADHD)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Las Vegas · Durham
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared Aptensio XR and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
Who is behind this study?
The study sponsor is Rhodes Pharmaceuticals, L.P.
Did this study involve medication?
Yes. The study involved medication, including Aptensio XR and Placebo.
Who was this study for?
Listed age limits: 4 years to 6 years.
